Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > TLTFF - The US SHORT report, better, BUT why any at all??
View:
Post by SouthernTierTom on Jan 29, 2022 10:38am

TLTFF - The US SHORT report, better, BUT why any at all??

Historical Short Volume Data for TLTFF
Date Close High Low Volume Short Volume % of Vol Shorted
Jan 28 NA NA NA 104,803 42,513 40.56
Jan 27 NA NA NA 41,763 32,612 78.09
Jan 26 NA NA NA 152,290 60,190 39.52
Jan 25 NA NA NA 121,876 62,632 51.39
Jan 24 NA NA NA 150,198 119,915 79.84
Jan 21 NA NA NA 132,485 85,520 64.55
Jan 20 NA NA NA 26,450 21,200 80.15
Jan 19 NA NA NA 277,962 83,412 30.01
Jan 18 NA NA NA 260,033 141,601 54.46
Jan 14 NA NA NA 53,726 45,200 84.13
Jan 13 NA NA NA 92,285 65,535 71.01
Jan 12 NA NA NA 115,840 104,240 89.99
Jan 11 NA NA NA 200,053 179,879 89.92
Jan 10 NA NA NA 31,171 8,271 26.53
Jan 07 NA NA NA 133,365 25,475 19.10
Jan 06 NA NA NA 56,346 5,150 9.14
Jan 05 NA NA NA 104,340 83,040 79.59
Jan 04 NA NA NA 166,550 143,250 86.01
Jan 03 NA NA NA 60,147 40,147 66.75
Dec 31 NA NA NA 250,826 95,581 38.11
Dec 30 NA NA NA 233,194 156,657 67.18
Comment by Legit62 on Jan 29, 2022 11:37am
Day traders trying to make a quick buck, once the squeeze starts they will need to cover and price going to shoot way up, very, very soon. I would not want to be a shorter with a company that has a cure for cancer, patient and long on this stock, well well  north of 500,000 shares,when the news breaks we go up fast and hard
Comment by menoalittle on Jan 29, 2022 1:23pm
actually, I don't believe there is much (if any, even) real shorting of stock on the usa side of the border. if anything, I see those numbers represent buyers of stock, which the brokers in the US do not have (nor keep) hardly any (if any) inventory of.  consequently, they mark the trade as a short sale... even though their automated system might turn right around and buy it back through ...more  
Comment by xodcode on Jan 29, 2022 3:59pm
Agreed: shorts are at risk of a fairly quick TLT price increase in the short term given the likelihood of imminent positive test results. Technically, needs to break $0.38, next resistance at $0.48 and last resistance at $0.58. Once through $0.58, no telling how far TLT runs!
Comment by Legit62 on Jan 29, 2022 5:36pm
You would think it should more than double if the trial is good and good news, cause you would figure there should be a lot more buying, 
Comment by 99942Apophis on Jan 29, 2022 8:53pm
Legit62 wrote You would think it should more than double if the trial is good and good news, cause you would figure there should be a lot more buying,  I agree Legit62 if the news is good and close to what we are expecting  it will blow right through those very old resistance points. Those old resistance points were at a time before PH2 had started, in charting one should pay more ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250